Intellectual Property and Vaccine Manufacturing: Utilizing Existing TRIPS Agreement Flexibilities for COVID-19 and Other Public Health Crises
Tulane Journal of Technology & Intellectual Property · 21.02.2024 · 25
DOI: 10.37381/43nsz093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tulane Journal of Technology & Intellectual Property, online erschienen am 21.02.2024. Verfasst von Andrew Mitchell und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mitchell, A., Taubman, A., & Samlidis, T. (2024). Intellectual Property and Vaccine Manufacturing: Utilizing Existing TRIPS Agreement Flexibilities for COVID-19 and Other Public Health Crises. Tulane Journal of Technology & Intellectual Property, 25. https://doi.org/10.37381/43nsz093
Vancouver
Mitchell A, Taubman A, Samlidis T. Intellectual Property and Vaccine Manufacturing: Utilizing Existing TRIPS Agreement Flexibilities for COVID-19 and Other Public Health Crises. Tulane Journal of Technology & Intellectual Property. 2024;25. doi:10.37381/43nsz093
BibTeX
@article{Mitchell2024,
author = {Mitchell, Andrew and Taubman, Antony and Samlidis, Theodore},
title = {Intellectual Property and Vaccine Manufacturing: Utilizing Existing TRIPS Agreement Flexibilities for COVID-19 and Other Public Health Crises},
journal = {Tulane Journal of Technology & Intellectual Property},
year = {2024},
volume = {25},
doi = {10.37381/43nsz093}
}
EUVIMED